If you want to prevent computer hackers from attacking medical devices, it's not enough to just design the best device you can before shipping it out the door.
Preventing cyberattacks in today's fast-changing wired world also requires med-tech companies and hospitals to continually look for problems in existing devices, and to communicate early and clearly when potential risks emerge, federal regulators say.
"Protecting medical devices from ever-shifting cybersecurity threats requires an all-out, life cycle approach that begins with early product development and extends throughout the product's life span," wrote Dr. Suzanne Schwartz, an associate director with the Food and Drug Administration's medical device division, on the official FDA Voice blog.
The FDA finalized a long-awaited set of guidelines last week on cybersecurity precautions for "postmarket" medical devices — devices that are already FDA approved, including those already sitting on hospital floors or inside patients' bodies.
The FDA's 30-page guidance strongly recommends device makers use active surveillance and threat-assessment tools to judge the likelihood that a new cybervulnerability affecting an older device will harm patients. If the severity of potential patient harm is high, but no patient has yet been hurt, the FDA wants device makers to inform their customers and users about the problem within 30 days, and come up with a fix in 60 days.
"I think the FDA is trying their hardest to encourage industry to adopt good practices when it comes to cybersecurity," said Ken Hoyme, a longtime Minnesota med-tech cybersecurity researcher who recently became Boston Scientific's director of product security.
At Minnesota-run Medtronic, cybersecurity is addressed proactively during the design stage and on an ongoing basis in the postmarket. The challenge is to add security features while still retaining the usability of the device, the company says.
"Device security, as well as any potential threat to patient safety, is taken very seriously at Medtronic," the company said in a recent performance report. "While we are not aware of any incident of unauthorized access or intrusion to an implanted device, device security is an area that is consistently addressed in the design process," and with independent analysis in the post-approval market.